PHARMFLY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMFLY
Largest movements
- Tangible fixed assets +€8,251
up €8,251 (+32.1%), from €25,707 to €33,958
of which Land and buildings: +€6,991
- Receivables within one year +€3,195
up €3,195 (+29.5%), from €10,836 to €14,032
of which Trade receivables: +€5,049
- Cash +€2,458
up €2,458 (+131.4%), from €1,871 to €4,329
mainly Net result for the year (+€23,116) and Depreciation (+€3,822)
- Profit (loss) carried forward +€23,116
up €23,116 (+28.7%), from -€80,457 to -€57,341
- Other debts -€11,821
down €11,821 (-15.5%), from €76,156 to €64,335
- Contributions -€3,130
down €3,130 (-9.1%), from €34,430 to €31,300
- Reserves +€3,130
up €3,130 (+77.4%), from €4,042 to €7,172
- Trade debts +€2,239
up €2,239 (+76.2%), from €2,939 to €5,179
- Gross operating margin +€7,531
up €7,531 (+30.8%), from €24,487 to €32,018
- Depreciation -€926
down €926 (-19.5%), from €4,747 to €3,822
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €39,670 | €53,584 | +€13,914 | +35.1% |
| Fixed assets | 21/28 | €25,707 | €33,958 | +€8,251 | +32.1% |
| Tangible fixed assets | 22/27 | €25,707 | €33,958 | +€8,251 | +32.1% |
| Land and buildings | 22 | €389 | €7,380 | +€6,991 | +1797.9% |
| Plant, machinery and equipment | 23 | €25,318 | €26,579 | +€1,260 | +5.0% |
| Furniture and vehicles | 24 | €0 | €0 | -€0 | -100.0% |
| Current assets | 29/58 | €13,963 | €19,625 | +€5,663 | +40.6% |
| Amounts receivable within one year | 40/41 | €10,836 | €14,032 | +€3,195 | +29.5% |
| Trade receivables | 40 | €8,469 | €13,518 | +€5,049 | +59.6% |
| Other amounts receivable | 41 | €2,368 | €514 | -€1,854 | -78.3% |
| Cash at bank and in hand | 54/58 | €1,871 | €4,329 | +€2,458 | +131.4% |
| Deferred charges and accrued income | 490/1 | €1,255 | €1,264 | +€9 | +0.7% |
| Total equity and liabilities | 10/49 | €39,670 | €53,584 | +€13,914 | +35.1% |
| Equity | 10/15 | -€41,985 | -€18,869 | +€23,116 | +55.1% |
| Contributions | 10/11 | €34,430 | €31,300 | -€3,130 | -9.1% |
| Reserves | 13 | €4,042 | €7,172 | +€3,130 | +77.4% |
| Distributable reserves | 133 | €4,042 | €7,172 | +€3,130 | +77.4% |
| Profit (loss) carried forward | 14 | -€80,457 | -€57,341 | +€23,116 | +28.7% |
| Amounts payable | 17/49 | €81,655 | €72,453 | -€9,202 | -11.3% |
| Amounts payable within one year | 42/48 | €81,655 | €72,453 | -€9,202 | -11.3% |
| Trade debts | 44 | €2,939 | €5,179 | +€2,239 | +76.2% |
| Suppliers | 440/4 | €2,939 | €5,179 | +€2,239 | +76.2% |
| Taxes, remuneration and social security | 45 | €2,559 | €2,939 | +€380 | +14.8% |
| Taxes | 450/3 | €2,559 | €2,939 | +€380 | +14.8% |
| Other amounts payable | 47/48 | €76,156 | €64,335 | -€11,821 | -15.5% |
| Non-recurring operating income | 76A | - | €2,107 | +€2,107 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,747 | €3,822 | -€926 | -19.5% |
| Other operating charges | 640/8 | €4,064 | €4,248 | +€184 | +4.5% |
| Non-recurring operating charges | 66A | - | €456 | +€456 | |
| Gross operating margin | 9900 | €24,487 | €32,018 | +€7,531 | +30.8% |
| Operating profit (loss) | 9901 | €15,676 | €23,492 | +€7,816 | +49.9% |
| Financial income | 75/76B | €265 | €22 | -€243 | -91.8% |
| Recurring financial income | 75 | €265 | €22 | -€243 | -91.8% |
| Financial charges | 65/66B | €128 | €255 | +€128 | +99.9% |
| Recurring financial charges | 65 | €128 | €255 | +€128 | +99.9% |
| Profit (loss) for the period before taxes | 9903 | €15,813 | €23,258 | +€7,445 | +47.1% |
| Income taxes | 67/77 | €141 | €143 | +€2 | +1.3% |
| Profit (loss) for the period | 9904 | €15,672 | €23,116 | +€7,443 | +47.5% |
| Profit (loss) for the period to be appropriated | 9905 | €15,672 | €23,116 | +€7,443 | +47.5% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.